Generic Name: Rituximab
Brand Name: Rituxan
Manufacturer: Hoffman-La Roche Ltd.
Therapeutic Area: Granulomatosis with polyangiitis and microscopic polyangiitis
Indications: Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA), remission induction (adults)
Submission Type: New Indication
Project Status: Complete
Date Recommendation Issued: August 16, 2012
Recommendation Type: List with clinical criteria and/or conditions